Why Joint Health Matters — and the Role of 4Cyte™ & Epiitalis® in Dogs and Horses
Osteoarthritis (OA) is one of the most common—and often under-recognised—conditions seen in veterinary practice today. Affecting both companion animals and performance horses, OA is a progressive, degenerative joint disease that can significantly impact mobility, comfort, and overall quality of life.
Osteoarthritis Awareness Month is an important opportunity for veterinary professionals to raise awareness, encourage early intervention, and highlight advances in joint health management—including innovative nutritional support such as 4Cyte™ and its key ingredient, Epiitalis®.
________________________________________
Understanding Osteoarthritis in Animals
OA is characterised by:
• Breakdown of articular cartilage
• Synovial inflammation
• Changes to subchondral bone
• Progressive joint dysfunction and pain
In dogs:
• Affects up to 1 in 5 adult dogs
• Common in ageing, overweight, or large breeds
• Signs are often subtle:
o Slowing down on walks
o Reluctance to jump or climb
o Behavioural changes
In horses:
• A leading cause of poor performance and early retirement
• Particularly prevalent in:
o Sport horses
o Racehorses
o Older leisure horses
Importantly, OA is not just a disease of “wear and tear”—it involves complex inflammatory and biochemical processes that continue to drive joint degeneration if left unmanaged.
________________________________________
The Challenge: Managing a Progressive Disease
There is no cure for osteoarthritis. Veterinary management focuses on:
• Pain control (e.g. NSAIDs)
• Weight management
• Exercise modification
• Joint support through nutrition
However, long-term reliance on pharmaceuticals can raise concerns around:
• Side effects
• Compliance
• Cost
This has driven increasing interest in adjunctive therapies that support joint health at a cellular level—enter Epiitalis® and 4Cyte™.
________________________________________
What is Epiitalis®?
Epiitalis® is a plant-derived extract (from Biota orientalis) that has been developed specifically to support joint health.
Unlike traditional joint supplements (e.g. glucosamine/chondroitin), Epiitalis works at a biological and cellular level, targeting key processes involved in osteoarthritis.
Key mechanisms of action:
✅ Supports chondrocyte proliferation (cartilage-forming cells)
✅ Helps reduce pro-inflammatory mediators
✅ Encourages joint repair pathways
✅ Supports maintenance of cartilage integrity
This makes it particularly relevant in a disease like OA, where cartilage breakdown and inflammation are ongoing processes.
________________________________________
What is 4Cyte™?
4Cyte™ is a veterinary joint health supplement formulated with Epiitalis® as its core active ingredient.
It is designed to:
• Support joint health in early-stage OA
• Improve comfort and mobility in established disease
• Assist in post-injury or post-surgical recovery
________________________________________
Benefits of 4Cyte™ in Dogs
Veterinary and owner-reported outcomes commonly include:
• Improved mobility and willingness to exercise
• Reduced stiffness, particularly after rest
• Increased quality of life in ageing dogs
Clinical relevance:
• Suitable for:
o Early intervention cases
o Chronic OA management
• Can be integrated alongside:
o NSAIDs
o Weight management programmes
o Physiotherapy
Its palatable gel form also supports compliance—an important factor in long-term conditions.
________________________________________
Benefits of 4Cyte™ in Horses
In equine practice, joint health is critical not just for welfare but for performance longevity.
Reported benefits include:
• Improved stride length and gait
• Increased willingness to work
• Support during intense training or competition schedules
Practical applications:
• Performance horse support
• Early degenerative joint disease
• Maintenance in older horses
The pellet formulation integrates easily into feeding routines—minimising disruption in stable management.
________________________________________
Why Epiitalis® Matters in Modern OA Management
Traditional supplements typically aim to:
• Provide building blocks (e.g. glucosamine)
Epiitalis® offers a different approach: Supporting the body’s own repair processes
This shift is important because:
• OA is driven by active degeneration, not just deficiency
• Supporting cellular activity may help:
o Slow disease progression
o Improve long-term outcomes
For veterinary professionals, this offers:
• A complementary tool alongside standard care
• A way to address owner demand for non-pharmaceutical options
________________________________________
Integrating 4Cyte™ into a Multimodal Plan
Best practice in OA management remains multimodal.
4Cyte™ can be positioned as part of a broader strategy:
🔹 Weight optimisation
🔹 Controlled exercise
🔹 Pain management
🔹 Physiotherapy or rehabilitation
🔹 Nutritional joint support
This integrated approach helps:
• Maximise patient comfort
• Improve adherence
• Deliver better long-term outcomes
________________________________________
Take-Home Message
Osteoarthritis remains a major welfare challenge in both dogs and horses—but advances in joint health support are changing how we manage this condition.
4Cyte™, powered by Epiitalis®, represents a shift toward biologically targeted joint care—supporting cartilage health, reducing inflammation, and helping animals move more comfortably for longer.
Contact DVS today to integrate 4Cyte™ into your OA management plans.
